专科用药是指针对特定疾病或系统性疾病开发的药物,通常具有明确的作用靶点和治疗目标。这类药物在研发过程中需要经过严格的临床试验验证其安全性和有效性。以下是几种常见的专科用药类别及其应用领域:
专科用药的研发需要依据药物化学的基本原理设计和合成化合物,并通过药理学、毒理学以及临床前研究来评估其潜在的疗效与安全性。此外,在药物上市之前还须经过严格的临床试验以确保药物对患者的安全性和有效性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
去铁胺 | deferoxamine | 70-51-9 | C25H48N6O8 |
|
卡泊芬净 | N-[(3S,9S,11R,18S,20R,21R,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide | 162808-62-0 | C52H88N10O15 |
|
卡泊三醇 | calcipotriene | 112965-21-6 | C27H40O3 |
|
全氟壬二酸 | tetradecafluoroazelaic acid | 23453-64-7 | C9H2F14O4 |
|
克罗米通 | crotamiton | 483-63-6 | C13H17NO |
|
依曲替酯 | etretinate | 54350-48-0 | C23H30O3 |
|
他扎罗汀 | tazarotene | 118292-40-3 | C21H21NO2S |
|
亚甲基蓝 | Methylene Blue trihydrate | 7220-79-3 | C16H24ClN3O3S |
|
亚甲基蓝 | methylene blue | 7220-79-3 | C16H18N3S*Cl*3H2O |
|
二硫化四乙基秋兰姆 | disulfiram | 97-77-8 | C10H20N2S4 |
|
二氟孕甾丁酯 | difluprednate | 23674-86-4 | C27H34F2O7 |
|
二巯基丙磺酸钠 | 2,3-dimercaptopropane-1-sulphonic acid | 74-61-3 | C3H8O3S3 |
|
二巯丁二钠 | Sodium dimercaptosuccinate | 71799-86-5 | C4H5NaO4S2 |
|
二乙烯三胺五醋酸 | diethylenetriaminopentaacetic acid | 67-43-6 | C14H23N3O10 |
|
乙酰胺 | acetamide | 60-35-5 | C2H5NO |
|
乙二胺四乙酸 | ethylenediaminetetraacetic acid | 60-00-4 | C10H16N2O8 |
|
三氯化铝 | aluminium trichloride | 7446-70-0 | AlCl3 |
|
三乙烯四胺 | triethylentetramine | 112-24-3 | C6H18N4 |
|
N-羟乙基乙二胺三乙酸 | N-(2-hydroxyethyl)ethylenediaminetriacetic acid | 150-39-0 | C10H18N2O7 |
|
N-叔丁基-十氢异喹啉-3(S)-甲酰胺 | (3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide | 136465-81-1 | C14H26N2O |
|
N,N-二甲基-N'-苯磺酰胺 | N,N-Dimethyl-N'-phenylsulfamid | 4710-17-2 | C8H12N2O2S |
|
D-青霉胺 | 3,3-dimethyl-D-cysteine | 771431-20-0 | C5H11NO2S |
|
9-顺式维甲酸 | 9-cis-retinoic acid | 5300-03-8 | C20H28O2 |
|
9-胺-1,2,3,4-四氢盐酸氯酯 | tacrin | 321-64-2 | C13H14N2 |
|
5-[3-(羧基甲氧基)苯基]-3-(4,5-二甲基-2-噻唑基)-2-(4-磺基苯基)-2H-四唑鎓内盐 | MTS | 138169-43-4 | C20H17N5O6S2 |
|
2,3-二巯基丙磺酸钠 | 4076-02-2 | C3H8NaO3S3 |
|
|
2,3-二巯基丁二酸 | 2,3-dimercapto-succinic acid | 2418-14-6 | C4H6O4S2 |
|
2,3-二巯基-1-丙醇 | 2,3-dimercaptopropanol | 59-52-9 | C3H8OS2 |
|
17a-羟基-11b-羟基-3-氧代雄甾-1,4-二烯-17-甲酸氯甲酯 | Loteprednol | 129260-79-3 | C21H27ClO5 |
|
(2Z,4E,6Z,8E)-3,7-二甲基-9-(2,6,6-三甲基-1-环己烯基)壬-2,4,6,8-四烯酸 | 9,13-di-cis-retinoic acid | 5352-74-9 | C20H28O2 |
|
(2-氨基-3-(4-溴苯甲酰)苯基)乙酸钠 | Bromfenac Sodium Sesquihydrate | 120638-55-3 | C30H28Br2N2Na2O9 |
|
—— | Metalcaptase | 52-67-5 | C5H13NO2S |
|
—— | 1-methyl-2-(nitrosomethylidene)pyridine;iodide | 94-63-3 | C7H8N2O*I |
|
—— | Collagens | 9007-34-5 | C25H48N4O5 |
|
—— | (+/-)-(1RS,4SR)acetic acid 4-acetylamido-cyclopent-2-enyl-methyl ester | 61865-50-7 | C10H15NO3 |
|
—— | 7775-11-3 | CrH2NaO4 |
|
|
—— | 10102-17-7 | H4NaO4S2 |
|
|
—— | Aluminum Potassium sulfate dodecchydrate | 7784-24-9 | AlH4KO5S |
|
—— | (1S,3S,5Z)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(E,2S)-5-Cyclopropyl-5-hydroxy-pent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol | 112965-21-6 | C27H40O3 |
|
—— | 1,1'-bis(pyridinium-4-aldoxime)trimethylene dibromide | 56-97-3 | 2Br*C15H18N4O2 |
|
—— | (1R,3R,5Z)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(E,2R)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | 112828-00-9 | C27H40O3 |
|
—— | lead acetate | 301-04-2 | C4H6O4Pb |
|
—— | (7Z)-calcipotriol | 112828-00-9 | C27H40O3 |
|
—— | 2-(4-ammonio-4-carboxy-butyrylamino)-2-(carboxymethyl-carbamoyl)-ethylsulfanyl | 70-18-8 | C10H16N3O6S*H |
|
—— | N-[(3S,6S,9S,11R,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide | 162808-62-0 | C52H88N10O15 |
|
—— | [5-[(1S,2S)-2-[(3S,9S,11R,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] hydrogen sulfate | 235114-32-6 | C56H71N9O23S |
|
—— | Cacodylic acid, sodium salt | 124-65-2 | C2H7AsNaO2+ |
|
—— | MK-0991 (Acetate);L-743872 (Acetate) | 179463-17-3 | C56H96N10O19 |
|
—— | Copper citrate | 866-82-0 | C6H8Cu2O7+4 |
|
—— | 1,1'-(Oxybis(methylene))bis(4-((hydroxyimino)methyl)pyridin-1-ium) chloride | 114-90-9 | C14H16Cl2N4O3 |
|